Tag archive for ‘Reuven Krupik’
Globes On Tuesday, October 7th, 2014

Clal Biotech, Hyperion seek settlement over Andromeda

– Clal Biotechnology and Hyperion have agreed on an independent assessment of Andromeda’s Type 1 diabetes treatment. –   Clal Biotechnology (TASE: CBI), managed by Reuven Krupik, and More...

Globes On Tuesday, September 23rd, 2014

Clal Biotech Suing Hyperion for $200 Million over ‘Rash and Ill Considered’ Andromeda Decisions

Clal Biotechnology Industries Ltd. (TASE: CBI announced yesterday that it had filed a $200 million suit against drug company Hyperion Therapeutics Inc. (Nasdaq: HPTX) in the US in the State of Delaware Court, More...

Wordpress site Developed by Fixing WordPress Problems